Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-576
Closed -$575K 194
2023
Q3
$575K Sell
576
-24
-4% -$2.68K ﹤0.01% 189
2023
Q2
$595K Hold
600
﹤0.01% 195
2023
Q1
$596K Buy
+600
New +$99K ﹤0.01% 186
2021
Q4
Sell
-1,764
Closed -$679K 247
2021
Q3
$679K Sell
1,764
-1,136
-39% -$419K 0.02% 157
2021
Q2
$681K Sell
2,900
-12,618
-81% -$2.25M 0.02% 156
2021
Q1
$2.03M Buy
15,518
+9,473
+157% +$1.37M 0.06% 114
2020
Q4
$632K Sell
6,045
-4,019
-40% -$407K 0.02% 147
2020
Q3
$712K Buy
10,064
+1,866
+23% +$130K 0.03% 126
2020
Q2
$526K Sell
8,198
-1,705
-17% -$93.4K 0.03% 140
2020
Q1
$297K Buy
+9,903
New +$228K 0.02% 169

Other funds holding MRNA

Quilter Plc's MRNA Position: Q4 2023 in Review

Quilter Plc sold out of Moderna (MRNA) in Q4 2023, closing a stake of 576 shares — an estimated $575K sold.

Quilter Plc first reported a position in MRNA in Q1 2020 and held it in 10 quarters. The position peaked at $2.03M in Q1 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Quilter Plc reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Quilter Plc sold 576 Moderna shares in Q4 2023, an estimated $575K.
  • Quilter Plc first reported a position in Moderna in Q1 2020 and held it in 10 quarters.
  • Quilter Plc's Moderna position peaked at $2.03M in Q1 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Quilter Plc's 13F filing for Q4 2023, filed 24 Jan 2024.